Gland Pharma has reported results for first quarter ended June 30, 2023 (Q1FY24).
The company has reported 18.25% fall in its net profit at Rs 187.58 crore for the quarter under review as compared to Rs 229.45 crore for the same quarter in the previous year. Total income of the company decreased by 1.29% at Rs 919.28 crore for Q1FY24 as compared Rs 931.29 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported 15.30% fall in net profit at Rs 194.10 crore for the first quarter ended June 30, 2023 as compared to Rs 229.17 crore for the same quarter in the previous year. However, total income of the company increased by 33.82% at Rs 1,246.24 crore for Q1FY24 as compared Rs 931.29 crore for the corresponding quarter previous year.
